跳至主要内容
临床试验/JPRN-UMIN000001861
JPRN-UMIN000001861尚未招募3 期

A randomized competitive trial of BCG instillation therapy with UFT for prevention of superficial bladder cancer recurrence. - BCG+UFT therapy for superficial bladder cancer

Study Group of Urothelial Cancer Kitasato institute hospital Kitasato University Kyorin University Keio University Showa University Teikyo University Tokyo Medical University Jikei University Toho University0 个研究点目标入组 354 人开始时间: 2009年5月1日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
354

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) TNM classification; Ta&G1, Ta&G2, T1&G1,initial, single, primary CIS. 2) Prior therapy of BCG and/or UFT. 3) Prior therapy of irradiation. 4) Presence of active other cancers. 5) Having a severe complications occurred within 3 months before this study; serious heart disease, severe hypertension, severe diabetes, severe angina, ileus, interstitial-Pneumonitis, lung fibrosis, heart failure, renal failure, liver dysfunction, severe infection. 6) HIV patient, need of steroid therapy. 7) Strong positivity for tuberculin test. 8) Presence of water severe diarrhea. 9) Contraindications for BCG or UFT.(According to attached files of BCG or UFT.) 10) Presence of severe allergy for medicines. 11) A pregnant women, a woman of breast-feeding, a woman who want to get pregnant. 12) A man who want to make pregnant.

研究者

发起方
Study Group of Urothelial Cancer Kitasato institute hospital Kitasato University Kyorin University Keio University Showa University Teikyo University Tokyo Medical University Jikei University Toho University

相似试验